Dauri M, Faria S, Gatti A, Celidonio L, Carpenedo R, Sabato A F
Department of Anaesthesiology, Emergency and Intensive Care Medicine, University Hospital of Tor Vergata, Rome, Italy.
Curr Drug Targets. 2009 Aug;10(8):716-33. doi: 10.2174/138945009788982513.
Gabapentin and pregabalin inhibit Ca(2+) currents via high-voltage-activated channels containing the alpha2delta-1 subunit, reducing neurotransmitter release and attenuating the postsynaptic excitability. They are antiepileptic drugs successfully used also for the chronic pain treatment. A large number of clinical trials indicate that gabapentin and pregabalin could be effective as postoperative analgesics. This systematic-narrative review aims to analyse the most recent evidences regarding the effect of gabapentinoids on postoperative pain treatment.
Medline, The Cochrane Library, EMBASE and CINHAL were searched for recent (2006-2009) randomized clinical trials (RCTs) of gabapentin-pregabalin for postoperative pain relief in adults. Quality of RCTs was evaluated according to Jadad method. Visual analogue scale (VAS), opioid consumption and side-effects (nausea, vomiting, dizziness and sedation) were considered the most important outcomes.
An overall of 22 gabapentin (1640 patients), 8 pregabalin (707 patients) RCTs and seven meta-analysis were involved in this review. Gabapentin provided better post-operative analgesia and rescue analgesics sparing than placebo in 6 of the 10 RCTs that administered only pre-emptive analgesia. Fourteen RCTs suggested that gabapentin did not reduce PONV when compared with placebo, clonidine or lornoxicam. Pregabalin provided better post-operative analgesia and rescue analgesics sparing than placebo in two of the three RCTs that evaluated the effects of pregabalin alone vs placebo. Four studies reported no pregabalin effects on preventing the PONV.
Gabapentin and pregabalin reduce pain and opioid consumption after surgery in confront with placebo, but comparisons with other standard post-operative regimens are not sufficient. Gabapentin and pregabalin seem not to have any influence on the prevention of PONV.
加巴喷丁和普瑞巴林通过含有α2δ-1亚基的高电压激活通道抑制钙电流,减少神经递质释放并减弱突触后兴奋性。它们是成功用于慢性疼痛治疗的抗癫痫药物。大量临床试验表明,加巴喷丁和普瑞巴林可作为术后镇痛药有效使用。本系统叙述性综述旨在分析关于加巴喷丁类药物对术后疼痛治疗效果的最新证据。
检索Medline、Cochrane图书馆、EMBASE和CINHAL,查找近期(2006 - 2009年)关于加巴喷丁 - 普瑞巴林用于成人术后疼痛缓解的随机临床试验(RCT)。根据Jadad方法评估RCT的质量。视觉模拟评分法(VAS)、阿片类药物消耗量和副作用(恶心、呕吐、头晕和镇静)被视为最重要的结果。
本综述共纳入22项加巴喷丁(1640例患者)、8项普瑞巴林(707例患者)的RCT以及7项荟萃分析。在仅给予超前镇痛的10项RCT中的6项中,加巴喷丁比安慰剂提供了更好的术后镇痛和节省补救性镇痛药的效果。14项RCT表明,与安慰剂、可乐定或氯诺昔康相比,加巴喷丁并未降低术后恶心呕吐(PONV)的发生率。在评估普瑞巴林单独与安慰剂效果的3项RCT中的2项中,普瑞巴林比安慰剂提供了更好的术后镇痛和节省补救性镇痛药的效果。4项研究报告普瑞巴林对预防PONV无作用。
与安慰剂相比,加巴喷丁和普瑞巴林可减轻术后疼痛并减少阿片类药物的消耗量,但与其他标准术后治疗方案的比较尚不充分。加巴喷丁和普瑞巴林似乎对预防PONV没有任何影响。